Contemporary practice patterns related to the risk of acute kidney injury in the catheterization laboratory: Results from a survey of Society of Cardiovascular Angiography and Intervention (SCAI) cardiologists

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Catheterization and cardiovascular interventions

• Publication date

  2017-02-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ccd.26628PMID 27315581
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevention of Contrast-Induced Nephropathy by Central Venous Pressure-Guided Fluid Administration in Chronic Kidney Disease and Congestive Heart Failure Patients.

  2016cited by this paper
• Mehran contrast nephropathy risk score: Is it still useful 10 years later?

  2016cited by this paper
• Effect of the Mehran risk score for the prediction of clinical outcomes after percutaneous coronary intervention.

  2015cited by this paper
• Comparison between theophylline, N-acetylcysteine, and theophylline plus N-acetylcysteine for the prevention of contrast-induced nephropathy

  2015cited by this paper
• CO2 angiography for peripheral arterial imaging

  2015cited by this paper
• 2014 ESC/EACTS guidelines on myocardial revascularization.

  2015cited by this paper
• Impact of Renin-Angiotensin-Aldosterone System-blocking Agents on the Risk of Contrast-induced Acute Kidney Injury: A Prospective Study and Meta-analysis

  2015cited by this paper
• Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patie

  2015cited by this paper
• Acute Kidney Injury in Patients With Chronic Kidney Disease Undergoing Internal Carotid Artery Stent Implantation.

  2015cited by this paper
• Occupational health hazards of interventional cardiologists in the current decade: Results of the 2014 SCAI membership survey

  2015cited by this paper
• The Effect of Renin-Angiotensin-Aldosterone System Blockade Medications on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography: A Meta-Analysis

  2015cited by this paper
• 2014 ESC/EACTS guidelines on myocardial revascularization.

  2015cited by this paper
• Pre- and/or Intra-Operative Prescription of Diuretics, but Not Renin-Angiotensin-System Inhibitors, Is Significantly Associated with Acute Kidney Injury after Non-Cardiac Surgery: A Retrospective Cohort Study

  2015cited by this paper
• Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: The POSEIDON randomised controlled trial

  2014cited by this paper
• Effects of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Contrast-Induced Nephropathy

  2014cited by this paper
• Pharmacological Strategies to Prevent Contrast-Induced Acute Kidney Injury

  2014cited by this paper
• Hemodynamic and Tubular Changes Induced by Contrast Media

  2014cited by this paper
• Effect of renin-angiotensin-system blockers on contrast-medium-induced acute kidney injury after coronary angiography

  2014cited by this paper
• Discomfort assessment in peripheral angiography: Randomized clinical trial of Iodixanol 270 versus Ioversol 320 in diabetics with critical limb ischemia

  2014cited by this paper
• ESC / EACTS Guidelines on myocardial revascularization

  2014influential reference
• Nephropathy after administration of iso-osmolar and low-osmolar contrast media: evidence from a network meta-analysis.

  2014cited by this paper
• Metformin in patients with type 2 diabetes and kidney disease: a systematic review.

  2014influential reference
• Impact of automated contrast injector systems on contrast use and contrast-associated complications in patients undergoing percutaneous coronary interventions.

  2013cited by this paper
• Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial.

  2013cited by this paper
• Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study

  2013cited by this paper
• Contrast medium volume to creatinine clearance ratio: A predictor of contrast‐induced nephropathy in the first 72 hours following percutaneous coronary intervention

  2012cited by this paper
• 2012 American college of cardiology foundation/society for cardiovascular angiography and interventions expert consensus document on cardiac catheterization laboratory standards update: American college of cardiology foundation task force on expert consensus documents society of thoracic surgeons so

  2012cited by this paper
• Section 4: Contrast-induced AKI

  2012cited by this paper
• 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

  2011influential reference
• Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions.

  2011cited by this paper
• Acetylcysteine for Prevention of Renal Outcomes in Patients Undergoing Coronary and Peripheral Vascular Angiography: Main Results From the Randomized Acetylcysteine for Contrast-Induced Nephropathy Trial (ACT)

  2011cited by this paper
• 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

  2011cited by this paper
• Contrast-induced acute kidney injury: specialty-specific protocols for interventional radiology, diagnostic computed tomography radiology, and interventional cardiology.

  2009cited by this paper
• The use of radiographic contrast media during PCI: A focused review

  2009cited by this paper
• The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials.

  2009cited by this paper
• Ultra-low contrast volumes reduce rates of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography.

  2008cited by this paper
• A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity

  2007cited by this paper
• Prevention of contrast induced nephropathy: Recommendations for the high risk patient undergoing cardiovascular procedures

  2007cited by this paper
• The ACIST power injection system reduces the amount of contrast media delivered to the patient, as well as fluoroscopy time, during diagnostic and interventional cardiac procedures

  2005cited by this paper
• A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect.

  2004cited by this paper
• A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation.

  2004cited by this paper
• Pain in femoral arteriography: A double-blind, randomized, clinical study comparing safety and efficacy of the iso-osmolar iodixanol 270mgI/ml and the low-osmolar iomeprol 300 mgI/ml in 9 European centers

  2003cited by this paper
• Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association.

  2001cited by this paper
• Dosing of contrast material to prevent contrast nephropathy in patients with renal disease.

  1989cited by this paper

• Current State of Simulation in Interventional Cardiology Training: Results of a SCAI Survey

  2025cites this paper
• SCAI Manual of Standard Operating Procedures for Performing Scientific Surveys

  2024cites this paper
• Key Considerations regarding the Renal Risks of Iodinated Contrast Media: The Nephrologist’s Role

  2023cites this paper
• DyeVert Contrast Reduction System Use in Patients Undergoing Coronary and/or Peripheral Angiography: A Systematic Literature Review and Meta-Analysis

  2022cites this paper
• How Much Contrast Media Can Be Used Safely in the Cardiac Catheterization Lab?

  2021cites this paper
• Post Contrast Acute Kidney Injury

  2020cites this paper
• Application of Fasudil in the Treatment of Contrast-Induced Acute Renal Insufficiency Based on Computerized Tomography Intelligent information monitoring (Preprint)

  2020cites this paper
• Nephrology Consultative Approach and Risk Stratification Prior to Revascularization in Chronic Kidney Disease

  2020cites this paper
• The Incidence and the Prognostic Impact of Acute Kidney Injury in Acute Myocardial Infarction Patients: Current Preventive Strategies

  2018cites this paper
• Minimizing radiographic contrast administration during coronary angiography using a novel contrast reduction system: A multicenter observational study of the DyeVert™ plus contrast reduction system

  2018influential citation
• PERIPHERAL VASCULAR DISEASE Original Studies Contrast Induced-Acute Kidney Injury following Peripheral Angiography with Carbon Dioxide versus Iodinated Contrast Media: A Meta-Analysis and Systematic Review of Current Literature

  2017cites this paper
• Post-Hoc Study: Intravenous Hydration Treatment in Chinese Patients with High Risk of Contrast-Induced Nephropathy Following Percutaneous Coronary Intervention

  2017cites this paper